Back to 
Vanguard Group Inc.
Vanguard Group Inc.
ERNA
2 quarters
Position history for Vanguard Group Inc.'s holdings in Ernexa Therapeutics Inc.
As of its last 13F, for Q4 2025, Vanguard Group held 35,922 shares of ERNA (Ernexa Therapeutics), worth $43,106. It increased the position from 11,147 shares in Q3 2025. Vanguard Group held ERNA from Q3 2025 to Q4 2025, across 2 quarterly 13F filings.
Current Value
$43,106
Current Shares
35,922
Total Value Change
+$30,900
Total Shares Change
+24,775
Quarter-by-Quarter History
Other major holders of ERNA: Corient Private Wealth LP, Geode Capital Management, LLC